Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection
NCT06084351
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Study Period Ended / Not Completed
Conditions
Covid19
Interventions
DRUG:
Convalescent Plasma
OTHER:
Standard of Care
Sponsor
Larkin Community Hospital